This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




NSH NEWS

NSH webinar: Microwave Staining of Microorganisms
NSH
Join us for our first webinar of the 2015 laboratory series with Zoe Ann Durkin, M.Ed., HT(ASCP). She will review the general characteristics of fungi, acid fast bacilli, and spirochetes correlating them to disease and infection. This presentation will bring relevance to the histology laboratory by exploring the use of microwave technology in an effort to reduce turnaround time of patient results. Remember to register for whole series by Jan. 28 to receive the discounted rate of $1,350!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




TOP STORIES


US lawmakers pass 'Ensuring Access to Clinical Trials Act of 2015' for rare disease research
Cystic Fibrosis News Today
U.S. lawmakers recently introduced new legislation that could greatly benefit thousands of Americans suffering from cystic fibrosis and other rare diseases with largely unmet clinical needs by helping them gain access to and participate in clinical trials without having to worry about their health coverage. The new bill, called the "Ensuring Access to Clinical Trials Act of 2015," was sponsored by a bipartisan group of senators and legislators.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Science at risk as young researchers increasingly denied research grants
Lab Manager
America's youngest scientists, increasingly losing research dollars, are leaving the academic biomedical workforce, a brain drain that poses grave risks for the future of science, according to an article published recently by Johns Hopkins University President Ronald J. Daniels.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  GBI Cost Effective Products

GBI Labs produces the largest selection of secondary detection kits, from single to multiple detection kits, with wide range host species. We provide FREE samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market with 20%-30% cost less.
 


The Scientist's 'Top 10 Innovations' for 2014 offer powerful new research tools to advance diagnostics and possibly find uses in clinical labs
Dark Daily
Pathologists and clinical laboratory scientists tracking the hottest new diagnostic technologies may be in interested in the 2014 list of "Top 10 Innovations" recently published by The Scientist. This is a competition and each year The Scientist has a panel of five experts in life sciences review the entries. Among this year's Top 10 Innovations are promising diagnostic tools and new technologies with the potential to disrupt the current state of healthcare.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Researchers open 'Pandora's box' of potential cancer biomarkers
Medical Xpress
A new analysis opens the door to discovery of thousands of potential new cancer biomarkers. Researchers at the University of Michigan Comprehensive Cancer Center analyzed the global landscape of a portion of the genome that has not been previously well-explored — long non-coding RNAs. This vast portion of the human genome has been considered the dark matter because so little is known about it. Emerging new evidence suggests that lncRNAs may play a role in cancer and that understanding them better could lead to new potential targets for improving cancer diagnosis, prognosis or treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword BIOMARKERS.




IN THE NEWS


Mayo fights stricter oversight of lab tests
Star Tribune
Proposed federal rules to require new government approval of certain tests developed in medical schools and private business laboratories have drawn cries of protest from the Mayo Clinic. The proposed rules would for the first time make labs designing the tests prove their effectiveness to the U.S. Food and Drug Administration. Test developers also would have to formally report to the government problems that occur with the tests after they become available.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Princeton engineers develop a non-invasive blood glucose test that uses imaging technology
Dark Daily
Glucose testing is both a headache and an opportunity for clinical laboratories here in the United States and across the globe. It is a headache because many point-of-care and patient self-test glucose devices in wide use today lack the reliability of glucose testing performed in medical laboratories that use sophisticated diagnostic instruments.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Baptist Health School of Histotechnology

The Baptist Health School of Histotechnology has an one-year online program that may be the program for you! A non-residential student must have access to an accredited Histology lab and completed 1080 hours of Histology lab experience prior to starting the program. Classes begin in July each year, so call today!
 


With CLIA waiver and widespread flu, Alere ramps up molecular test production
GenomeWeb
In emergency rooms and physician's offices, lateral flow immunoassays are often used when rapid results matter for patient outcomes. Nucleic acid amplification tests are usually more specific and sensitive, but require laboratory technicians, and the very fastest U.S. Food and Drug Administration-approved tests still take about 90 minutes. Now, a 15-minute molecular influenza test on the Alere i platform has received CLIA waiver, allowing rapid molecular testing in low-complexity settings and potentially providing clinicians the best of both worlds.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of Under The Microscope? Click here to visit the Under The Microscope archive page.


PRODUCT SHOWCASE
  Hassle Free Block Storage Cabinet

Avantik Biogroup is proud to introduce another Customer Requested Quality Innovation for Histology...the Avantik Biogroup Block Storage Cabinet! We introduced Hassle-Free Drawer Technology with Interlocking Stackability and More Clearance between the top of the blocks and the drawers to achieve the industry's first Jam-Free, Hassle-Free Block Storage Cabinet!
 


Random chance's role in cancer
The New York Times
Unlike Ebola, flu or polio, cancer is a disease that arises from within — a consequence of the mutations that inevitably occur when one of our 50 trillion cells divides and copies its DNA. Some of these genetic misprints are caused by outside agents, chemical or biological, especially in parts of the body — the skin, the lungs and the digestive tract — most exposed to the ravages of the world. But millions every second occur purely by chance — random, spontaneous glitches that may be the most pervasive carcinogen of all.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Researchers reveal key factor in understanding elevated cancer risk linked to gene therapy
News-Medical.Net
National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy. They conducted research on mice with a rare disease similar to one in humans, hoping their findings may eventually help improve gene therapy for humans. Researchers at the National Human Genome Research Institute, part of NIH, published their research in the Jan. 20, 2015, online issue of the Journal of Clinical Investigation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Pathologists use ProExC antibody cocktail to determine tumor recurrence (News-Medical.Net)
New findings reveal genetic brain disorders converge at the synapse (HealthCanal)
Johnson & Johnson to make clinical data available to outside researchers (The New York Times)
Lab-grown human muscle is a medical breakthrough (CNET)
Platelet transfusions increase odds of death in some rare blood cell disorders (Medical Xpress)

Don't be left behind. Click here to see what else you missed.


 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Jan. 14, 2015
Jan. 7, 2015
Dec. 31, 2014
Dec. 23, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063